^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
maplirpacept (TTI-622)
i
Other names: TTI-622, PF-07901801, TTI622, TTI 622, SIRPa-IgG4-Fc, PF 07901801, PF07901801
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Pfizer
Drug class:
CD47 inhibitor
Related drugs:
